Back to search

Article

Tunable, proteolytic dosage control of CRISPR-Cas systems enables precise gene therapy for dosage sensitive disorders

2024-10-09

Abstract excerpt

<h4>Summary</h4> The ability to modulate gene expression through modular and universal genetic tools like CRISPR-Cas has greatly advanced gene therapy for therapeutics and basic science. Yet, the inherent stochasticity of delivery methods cause variation in target gene expression at the single-cell level, limiting their applicability in systems that require more precise expression. Thus, we implement a modular in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a66a331d-2ae8-5533-a81d-b4fd96497a40
DOI
10.1101/2024.10.09.617463
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tunable, proteolytic dosage control of CRISPR-Cas systems enables precise gene therapy for dosage sensitive disordersDOI 10.1101/2024.10.09.617463
Select a neighboring publication to make it the new centre.